Early Planning & Modelling

  • Parexel Simplifies Access to Knowledge2:48

    Parexel Simplifies Access to Knowledge

    A new report by the Economist Intelligence Unit (EIU) and commissioned by Parexel International Corporation reveals that new innovations in drug development have a positive impact on clinical trial ti

    Watch Video
  • See how our experts can add value to your strategy

    Learn More ►
  • ×

    Speak to one of our experts today

    First Name
    Last Name
    Company Name
    Title
    Country
    Tell us how we can help
    We'll be in touch shortly!
    Error - something went wrong!
  • The Increasingly Important Role of Real-World Evidence in CE modeling

    The Increasingly Important Role of Real-World Evidence in CE modeling

    The methods used to estimate cost-effectiveness of health technologies are constantly evolving. Early approaches in economic evaluation for health technologies relied primarily on the use of evidence.

    Read More
  • Get your free evidence readiness score today!

    Take Assessment
  • Innovative Clinical Trial Designs — Welcomed By Regulators But What About The Payers?

    Innovative Clinical Trial Designs — Welcomed By Regulators But What About The Payers?

    View Now
  • Presentation Slides: Early Engagement Strategies Webinar

    Presentation Slides: Early Engagement Strategies Webinar

    View Now
  • Promoting the patient voice in evidence generation and global market-access planning

    Promoting the patient voice in evidence generation and global market-access planning

    Presentation from the Medical Affairs Leaders Forum, London. February 27 - March 01, 2018

    View Now
  • Biosimilar mAbs – a unique and distinct market (for the time being…?)

    Biosimilar mAbs – a unique and distinct market (for the time being…?)

    Read More
  • The UK Early Access to Medicines Scheme: A 2-Year Status Update On Success, Issues and Controversies

    The UK Early Access to Medicines Scheme: A 2-Year Status Update On Success, Issues and Controversies

    Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

    Read More
  • Treatment Efficacy in Sequence Modelling - A Review of Published Approaches

    Treatment Efficacy in Sequence Modelling - A Review of Published Approaches

    Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

    Read More
  • Integrated Development Is How You Win Approval, Reimbursement And Differentiation

    Integrated Development Is How You Win Approval, Reimbursement And Differentiation

    View Now
  • Nice's Criteria for End-Of-Life Therapies: Is There a Fourth Hurdle to Overcome?

    Nice's Criteria for End-Of-Life Therapies: Is There a Fourth Hurdle to Overcome?

    Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

    Read More
  • Is There Evidence of a Difference Between Willingness to Pay and Willingness to Accept Thresholds? A Review of Nice Technology Appraisals

    Is There Evidence of a Difference Between Willingness to Pay and Willingness to Accept Thresholds? A Review of Nice Technology Appraisals

    Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

    Read More
  • Extrapolation of Time-To-Event Data in Various Disease Areas: Current Recommendations and Gaps

    Extrapolation of Time-To-Event Data in Various Disease Areas: Current Recommendations and Gaps

    Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

    Read More
  • Evidence of Value: How to Build A Robust Argument

    Evidence of Value: How to Build A Robust Argument

    Learn more about how to achieve regulatory and payer approval for drug discovery here!

    View Now
  • Considerations in Biosimilars Development – A US FDA Perspective

    Considerations in Biosimilars Development – A US FDA Perspective

    Read this presentation to find out more!

    Read More
  • The Evolution of Drug Development and Market Access via Connected Data-Driven Solutions

    The Evolution of Drug Development and Market Access via Connected Data-Driven Solutions

    The Connected Journey™ of data-driven services powered by PAREXEL® Analytics

    View Presentation
  • Early Economic Models pay off in Product Development

    Early Economic Models pay off in Product Development

    Read this article to find out how early economic models pay off in product development.

    View Now
  • Five Ways to ensure your Early Engagement with Payers and Regulators Pays Off

    Five Ways to ensure your Early Engagement with Payers and Regulators Pays Off

    Read here about how PAREXEL Integrates clinical and commercial evidence planning.

    View Now
  • loading
    Loading More...